As the world continues to adapt to the global public health situation, cancer immunotherapy drug developers are still actively seeking external partners that can provide solutions to the challenges they are facing as they aim to advance neoantigen targeting immunotherapies.
The 4th Neoantigen Summit Europe offers a unique opportunity to collaborate with key industry decision-makers in the space.
We’ll work with you to build a bespoke partnership package focused on making valuable connections and generating actionable leads to ensure you meet your 2020 commercial objectives in this new digital reality.
Maximize the 2:1 balance of live content and targeted online networking to generate leads and build new relationships with senior-level decision-makers from leading pharma and biotech companies.
Secure a branding or speaking opportunity to demonstrate thought leadership, drive brand exposure and differentiate yourself from competitors.
Secure a virtual exhibition booth to showcase your expertise and educate the industry on how you can support and streamline their efforts.
Embrace the tech to meet your 2020 commercial objectives and educate key decision-makers on how your expertise can help the neoantigen community achieve their full potential and reach patients in need.
- Showcase your expertise and educate the industry on how you can support and streamline their efforts
- Build new relationships via targeted networking with senior level decision makers from leading pharma and biotech organisations
- Drive your brand and cement your reputation to maximise exposure and differentiate yourself from competitors
Available Partnership Opportunities Include
Position yourself as a thought leader and educate your market
Curate and drive the conversation alongside leaders of the field
Interact intimately with your market audience to understand their needs
Exclusive VIP Hosting
Build or cement relationships through informal channels
Have your flag in the ground and let the onsite community know where you are